BioTech Medics (BioTech Medics) EV-to-FCF : (As of May. 17, 2024)

View and export this data going back to . Start your Free Trial

What is BioTech Medics EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, BioTech Medics's Enterprise Value is $3.85 Mil. BioTech Medics does not have enough years/quarters to calculate its Free Cash Flow for the trailing twelve months (TTM) ended in . 20. Therefore, GuruFocus does not calculate BioTech Medics's EV-to-FCF at this moment.

The historical rank and industry rank for BioTech Medics's EV-to-FCF or its related term are showing as below:

BMCS's EV-to-FCF is not ranked ^*
in the Drug Manufacturers industry.
Industry Median: 24.13
* Ranked among companies with meaningful EV-to-FCF only.

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-17), BioTech Medics's stock price is $0.019. BioTech Medics does not have enough years/quarters to calculate its Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in . 20. Therefore, GuruFocus does not calculate BioTech Medics's PE Ratio at this moment.

BioTech Medics EV-to-FCF Historical Data

The historical data trend for BioTech Medics's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioTech Medics EV-to-FCF Chart

BioTech Medics Annual Data

Trend

EV-to-FCF

BioTech Medics Quarterly Data

EV-to-FCF

Competitive Comparison of BioTech Medics's EV-to-FCF

For the Drug Manufacturers - Specialty & Generic subindustry, BioTech Medics's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

BioTech Medics's EV-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, BioTech Medics's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where BioTech Medics's EV-to-FCF falls into.

BioTech Medics EV-to-FCF Calculation

BioTech Medics's EV-to-FCF for today is calculated as:

EV-to-FCF	=	Enterprise Value (Today)	/	Free Cash Flow (TTM)
	=	3.845	/
	=

BioTech Medics (OTCPK:BMCS) EV-to-FCF Explanation

BioTech Medics's PE Ratio for today is calculated as:

PE Ratio	=	Share Price (Today)	/	Earnings per Share (Diluted) (TTM)
	=	0.019	/
	=

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.

BioTech Medics EV-to-FCF Related Terms

Thank you for viewing the detailed overview of BioTech Medics's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.

BioTech Medics (BioTech Medics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » BioTech Medics Inc (OTCPK:BMCS) » Definitions » EV-to-FCF

Comparable Companies

Traded in Other Exchanges

N/A

Address

5850 Canoga Avenue, Suite 400, Woodland Hills, Los Angeles, CA, USA, 91367

Website

http://www.biotecmedics.com

BioTech Medics Inc is a medical-based holding company. The company operates through four divisions namely Medical, Nutraceutical Products, Sports Medicine, and Research and Development.